Important pharmacy news and late-breaking industry information updated daily.

Now a fourth potential carcinogen is being linked to the popular blood pressure medication valsartan. FDA has been informed that a solvent called dimethylformamide (DMF) was discovered in valsartan made by several companies, including Novartis. DMF is classified by the World Health Organization as a probable carcinogen.

Twenty companies raised the list prices of more than 40 prescription drugs by an average of 13.1% on Monday, according to Rx Savings Solutions. On July 1 last year, 16 companies raised the list prices of dozens of drugs by an average 7.8%. Drug companies had typically raised list prices at the start of the year and again 6 months later.

Use of short-acting exenatide with and without basal insulin in noncritically ill hospitalized patients improved glycemic control and was well tolerated, according to data published in Diabetes Care.

As foreign-made generic blood-pressure medications tainted with probable carcinogens continue to be recalled, U.S. lawmakers are seeking more information about regulators' capacity to protect the nation's drug supply. House Energy and Commerce Committee Chairman Rep. Frank Pallone (D-NJ) and Rep.

The Infectious Diseases Society of America (IDSA), along with other organizations, released a draft of new guidelines for the prevention, diagnosis, and treatment of Lyme disease.

FDA approved on Thursday eculizumab (Soliris—Alexion Pharmaceuticals) injection for I.V. use for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive. The rare autoimmune disease of the central nervous system primarily affects the optic nerves and spinal cord.

FDA approved on Wednesday dupilumab (Dupixent—Regeneron Pharmaceuticals) for the treatment of adults with nasal polyps accompanied by chronic rhinosinusitis.

San Francisco's Board of Supervisors voted unanimously Tuesday to ban the sale and distribution of e-cigarettes in the city, a move that seeks to curb what experts have described as a nicotine epidemic among teenagers.

A small study could have big insights for opioid use after surgery. Greater opioid quantity for postsurgery patients has been associated with the development of addiction, noted authors of a study published in JAMA on June 25. Their study looked at whether reducing the number of opioid tablets prescribed after anterior cruciate ligament (ACL) knee surgery at a single academic ambulatory surgery center would reduce postoperative use, and if preoperative opioid-use education could reduce it even more.

President Donald Trump on Monday signed an executive order intended to give Americans more information about the cost and quality of health care services to help them comparison shop before they get care.